The Phase III trial is set to use growth outcomes as its primary endpoint in the 52-week trial of JR-142, a long-acting growth hormone.

While excessive alcohol consumption has serious health consequences, a new multicentre study provides new evidence that ...

The study was carried out in 1,232 participants in the PREDIMED project, a major scientific epidemiological study in ...

This is needed as the optimal treatment for shoulder pain remains unclear.9 The objective of this multicentre longitudinal cohort study was to identity which patient and clinical characteristics, ...

Correspondence to Dr Dennis Den Hartog, Trauma Research Unit, Department of Surgery, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands; ...

Symptom recovery trajectories in children aged 5 to 12 years of age suffering from sport-related concussions (SRCs) and ...

SetPoint Medical’s vagus nerve stimulator offers another treatment option for patients who do not properly respond to drug-based approaches.

Aflibercept is a vascular endothelial growth factor (VEGF) inhibitor used to treat Neovascular (Wet) Age-Related Macular ...

After detailed deliberation, the committee recommended that the firm should submit a revised protocol for the conduct of ...